Ancestry (6)
- ALL_PC1 - First principal component based on analysis that include all participatants (phv00481632.v1.p1)
- ALL_PC2 - Seond principal component based on analysis that include all participatants (phv00481633.v1.p1)
- ALL_PC3 - Third principal component based on analysis that include all participatants (phv00481634.v1.p1)
- ByRace_PC1 - First principal component based on analysis within race (phv00481635.v1.p1)
- ByRace_PC2 - Second principal component based on analysis within race (phv00481636.v1.p1)
- GENETIC_RACE - Genetically defined race based on principal component analysis from GWAS (phv00481631.v1.p1)
Anthropometry (1)
- BMI - Body mass index (phv00481629.v1.p1)
Demographics (3)
- AGE - Age (phv00481626.v1.p1)
- SEX - Biological sex (phv00481628.v1.p1)
- SEX - Biological sex (phv00481622.v1.p1)
Disease Events (2)
- NOD - New-onset diabetes (phv00481638.v1.p1)
- PO - Primary outcome: composite of all-cause death, nonfatal MI, nonfatal stroke (phv00481637.v1.p1)
Race and Ethnicity (1)
- RACE - Self-identified race (phv00481630.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00481644.v1.p1)
- ASSIGN - Randomization assignment of INVEST study (phv00481627.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00481643.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00481621.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00481645.v1.p1)
- NODCC - To be included in the new-onset diabetes case control analysis (phv00481640.v1.p1)
- POCC - To be included in the primary outcome case control analysis (phv00481639.v1.p1)
- RHTN - Resistant hypertension defined at the last visit/event, 1349 patients were categorized (phv00481641.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00481642.v1.p1)
- SAMPLE_ID - Sample ID (phv00481624.v1.p1)
- SUBJECT_ID - Study participant ID (phv00481625.v1.p1)
- SUBJECT_ID - Subject ID (phv00481620.v1.p1)
- SUBJECT_ID - Subject ID (phv00481623.v1.p1)